Arteriovenous Malformations Workup
- Author: Souvik Sen, MD, MPH, MS, FAHA; Chief Editor: Helmi L Lutsep, MD more...
See the list below:
- High-quality imaging studies are the key to diagnosis of AVMs.
- CT scan
- CT scanning easily identifies an intracerebral hemorrhage, raising suspicion of AVM in a younger person or a patient without clear risk factors for hemorrhage.
- CT scan can identify only large AVMs.
- MRI is essential for initial diagnosis of AVMs.
- AVMs appear as irregular or globoid masses anywhere within the hemispheres or brain stem, as shown in the images below.Axial T2 MRI showing an arteriovenous malformation with hemorrhage, in the territory of the left posterior cerebral artery.
- AVMs may be cortical, subcortical, or in deep gray or white matter.
- Small, round, low-signal spots within or around the mass on T1, T2, or fluid-attenuated inversion recovery (FLAIR) sequences are the "flow voids" of feeding arteries, intranidal aneurysms, or draining veins.
- If hemorrhage has occurred, the mass of blood may obscure other diagnostic features, requiring angiogram or follow-up MRI.
- Low signal of extracellular hemosiderin may be seen around or within the AVM mass, indicating prior symptomatic or asymptomatic hemorrhage.
- Larger aneurysms within the AVM or on feeding arteries may be identified occasionally.
- Magnetic resonance angiography (MRA) may identify AVMs greater than 1 cm in size, as in the image below, but is inadequate to delineate the morphology of feeding arteries and draining veins; small aneurysms can be missed easily.
- A retrospective analysis demonstrated that silent intralesional microhemorrhage on CT/MRI may be a risk factor for intracerbral hemorrhage from a brain AVM rupture.
- Cerebral angiography
- Angiogram, shown below, is required for hemodynamic assessment, which is essential for planning treatment.
- The morphology of the AVM determines the treatment algorithm. Important features include feeding arteries, venous drainage pattern, and arterial and venous aneurysms.
- Ten to fifty-eight percent of patients with AVM have aneurysms located in vessels remote from the AVM, in arteries feeding the AVM, or within the nidus of the AVM itself.
- Intranidal aneurysms may have a higher risk of rupture than those outside the bounds of the AVM.
- Other important angiographic features may include kinking or ectasia of draining veins, which can cause venous congestion, thrombosis, or rupture; and stenosis of feeding arteries due to angiopathy caused by high-velocity, turbulent flow into the fistula.
- Special expertise is required to perform superselective catheterization into AVM feeding arteries, which allows both pressure measurements and superselective anesthetic injections to map neurological function in and around the AVM (see Superselective angiography in Procedures).
Based on flow-velocity and resistance pattern, transcranial Doppler (TCD) has been demonstrated to be a noninvasive and cost-effective means to detect and follow brain AVMs. Recently, TCD has been found to be a reliable, safe, and noninvasive method to monitor the outcome of gamma knife surgery for brain AVMs.
See the list below:
- Superselective angiography
- Superselective angiography is performed with standard cerebral angiography, with access via a femoral artery puncture.
- A special, flexible, directable catheter is threaded up into one of the main cerebral arteries (carotid or vertebral), then into sequentially smaller branch arteries, until the catheter tip is near or within the AVM nidus.
- Pressure measurements can be obtained via a coaxial catheter. Higher feeding pressures increase the risk of subsequent hemorrhage.
- Sodium amytal, an anesthetic agent, can be injected to produce temporary anesthesia of the area perfused by the artery. In this so-called "superselective Wada testing," language, memory, visual-spatial, sensory, and motor function can be tested during 5 minutes of anesthetic effect to determine whether "eloquent" function originates in that region, which would therefore be at risk for neurological deficits should that brain area be injured during embolization or surgery. Arteries directly feeding the AVM or "en passage" vessels that feed the AVM but continue past the AVM to feed normal brain tissue can be studied.
Guo YH, Chen HX, Xie RM. [Effects of qi-supplementing dominated Chinese materia medica combined with rehabilitation training on the quality of life of ischemic post-stroke fatigue patients of qi deficiency syndrome]. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2012 Feb. 32(2):160-3. [Medline].
[Guideline] Ogilvy CS, Stieg PE, Awad I, Brown RD Jr, Kondziolka D, Rosenwasser R. AHA Scientific Statement: Recommendations for the management of intracranial arteriovenous malformations: a statement for healthcare professionals from a special writing group of the Stroke Council, American Stroke Association. Stroke. 2001 Jun. 32(6):1458-71. [Medline].
Weinsheimer S, Kim H, Pawlikowska L, Chen Y, Lawton MT, Sidney S, et al. EPHB4 gene polymorphisms and risk of intracranial hemorrhage in patients with brain arteriovenous malformations. Circ Cardiovasc Genet. 2009 Oct. 2(5):476-82. [Medline].
Laakso A, Dashti R, Juvela S, Niemelä M, Hernesniemi J. Natural history of arteriovenous malformations: presentation, risk of hemorrhage and mortality. Acta Neurochir Suppl. 2010. 107:65-9. [Medline].
Stapf C, Mast H, Sciacca RR, Berenstein A, Nelson PK, Gobin YP, et al. The New York Islands AVM Study: design, study progress, and initial results. Stroke. 2003 May. 34(5):e29-33. [Medline].
Mast H, Young WL, Koennecke HC. Risk of spontaneous haemorrhage after diagnosis of cerebral arteriovenous malformation. Lancet. 1997 Oct 11. 350(9084):1065-8. [Medline].
Halim AX, Johnston SC, Singh V. Longitudinal risk of intracranial hemorrhage in patients with arteriovenous malformation of the brain within a defined population. Stroke. 2004 Jul. 35(7):1697-702. [Medline].
Park SH, Hwang SK. Transcranial Doppler study of cerebral arteriovenous malformations after gamma knife radiosurgery. J Clin Neurosci. March 2009. 16(3):378-384.
ARUBA Investigators. Unruptured brain arteriovenous malformation trial. [The Internet Stroke Center]. Feb 2006. [Full Text].
ARUBA Study. Unruptured brain arteriovenous malformation trial. [ARUBA Study Site]. Feb 2006. [Full Text].
Lawton MT, Kim H, McCulloch CE, Mikhak B, Young WL. A Supplementary Grading Scale for Selecting Patients With Brain Arteriovenous Malformations for Surgery. Neurosurgery. 2010. 66(4):702-713.
Hernesniemi J, Romani R, Lehecka M, Isarakul P, Dashti R, Celik O, et al. Present state of microneurosurgery of cerebral arteriovenous malformations. Acta Neurochir Suppl. 2010. 107:71-6. [Medline].
Sahlein DH, Mora P, Becske T, Nelson PK. Nidal embolization of brain arteriovenous malformations: rates of cure, partial embolization, and clinical outcome. J Neurosurg. 2012 Apr 27. [Medline].
Parkhutik V, Lago A, Tembl JI, et al. Postradiosurgery hemorrhage rates of arteriovenous malformations of the brain: influencing factors and evolution with time. Stroke. 2012 May. 43(5):1247-52. [Medline].
Kano H, Kondziolka D, Flickinger JC, et al. Stereotactic radiosurgery for arteriovenous malformations after embolization: a case-control study. J Neurosurg. 2012 May 25. [Medline].
Sheehan J. Radiosurgery. J Neurosurg. 2012 Jan. 116(1):1-2; discussion 9-10. [Medline].
Castel JP, Kantor G. [Postoperative morbidity and mortality after microsurgical exclusion of cerebral arteriovenous malformations. Current data and analysis of recent literature]. Neurochirurgie. 2001 May. 47(2-3 Pt 2):369-83. [Medline].
Al-Shahi R, Bhattacharya JJ, Currie DG, Papanastassiou V, Ritchie V, Roberts RC, et al. Prospective, population-based detection of intracranial vascular malformations in adults: the Scottish Intracranial Vascular Malformation Study (SIVMS). Stroke. 2003 May. 34(5):1163-9. [Medline].
ApSimon HT, Reef H, Phadke RV, Popovic EA. A population-based study of brain arteriovenous malformation: long-term treatment outcomes. Stroke. 2002 Dec. 33(12):2794-800. [Medline].
Boggs W. Stereotactic Brain Radiosurgery Helps Small Unruptured Arteriovenous Malformations. Medscape Medical News. Jan 08 2013. [Full Text].
Flickinger JC, Kondziolka D, Lunsford LD, Pollock BE, Yamamoto M, Gorman DA. A multi-institutional analysis of complication outcomes after arteriovenous malformation radiosurgery. Int J Radiat Oncol Biol Phys. 1999 Apr 1. 44(1):67-74. [Medline].
Hartmann A, Mast H, Mohr JP, Pile-Spellman J, Connolly ES, Sciacca RR. Determinants of staged endovascular and surgical treatment outcome of brain arteriovenous malformations. Stroke. 2005 Nov. 36(11):2431-5. [Medline]. [Full Text].
Hillman J. Population-based analysis of arteriovenous malformation treatment. J Neurosurg. 2001 Oct. 95(4):633-7. [Medline].
Hofmeister C, Stapf C, Hartmann A, et al. Demographic, morphological, and clinical characteristics of 1289 patients with brain arteriovenous malformation. Stroke. 2000 Jun. 31(6):1307-10. [Medline]. [Full Text].
Maruyama K, Kawahara N, Shin M. The risk of hemorrhage after radiosurgery for cerebral arteriovenous malformations. N Engl J Med. 2005 Jan 13. 352(2):146-53. [Medline].
Nataf F, Ghossoub M, Schlienger M. Bleeding after radiosurgery for cerebral arteriovenous malformations. Neurosurgery. 2004 Aug. 55(2):298-305; discussion 305-6. [Medline].
Pollock BE, Link MJ, Brown RD. The Risk of Stroke or Clinical Impairment After Stereotactic Radiosurgery for ARUBA-Eligible Patients. Stroke. 2013 Jan 3. [Medline].